Douglas Yee

25PUBLICATIONS

115CO-AUTHORS

Cancer geneticsMolecular targetsTumour immunologyMedical devicesReproductive medicine not elsewhere classified

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (25)

Sort by Publication Date:

|Jul 08, 2026

mRNA and protein expression of fetal insulin receptor in breast cancer cell lines and tissues.

|Mar 20, 2026

Tumor-specific lncRNA IGF1R-AS1 trans-regulates chromatin interactions associated with oncogenic MYC signaling.

Yongyong Yang, Ting-You Wang, Joshua Fry

|Dec 31, 2025

mRNA and Protein Expression of Fetal Insulin Receptor in Breast Cancer Cell Lines.

Xihong Zhang, Albert Barrios, LeeAnn Higgins

|Sep 04, 2025

Immune and Growth Factor Signaling Pathways Are Associated with Pathologic Complete Response to an Anti-Type I Insulin-like Growth Factor Receptor Regimen in Patients with Breast Cancer.

Emmanuel F Petricoin, Denise M Wolf, Christina Yau

|Jun 17, 2025

Immune Subtyping Identifies Patients With Hormone Receptor-Positive Early-Stage Breast Cancer Who Respond to Neoadjuvant Immunotherapy (IO): Results From Five IO Arms of the I-SPY2 Trial.

Denise M Wolf, Christina Yau, Michael Campbell

|Sep 14, 2024

Datopotamab-deruxtecan plus durvalumab in early-stage breast cancer: the sequential multiple assignment randomized I-SPY2.2 phase 2 trial.

Rebecca A Shatsky, Meghna S Trivedi, Christina Yau

Pageof 5

Frequent Collaborators

Gillian L Hirst

Laura Van't Veer

Laura J Esserman

Lamorna Brown-Swigart

Angela M DeMichele

Rita Nanda

Hope S Rugo

W Fraser Symmans

Claudine Isaacs

Paula R Pohlmann

Frequent Collaborators

Gillian L Hirst

Laura Van't Veer

Laura J Esserman

Lamorna Brown-Swigart